| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &CFO
1 company
Coyne Terrance P. is an EVP &CFO at Royalty Pharma plc. Recent SEC Form 4 filings include 2 buys and 7 sells.
Estimated insider holdings value: $2.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2022 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 30,000 | $43.19 | $1,295,727.00 | -3.0% | -0.6% | -27.1% | |
| Mar 3, 2021 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 100,000 | $44.78 | $4,478,450.32 | -10.2% | - | - | |
| Mar 2, 2021 | RPRX Royalty Pharma Plc | EVP &CFO | Sell | 100,000 | $46.94 | $4,694,090.14 | -14.2% | - | - | |
| Jun 18, 2020 | RPRX Royalty Pharma Plc | EVP &CFO | Buy | 2,950 | $28.00 | $82,600.00 | New | - | - |